Stent Retriever Thrombectomy for Thrombus Burden Reduction in Patients With Acute Myocardial Infarction - RETRIEVE-AMI Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Myocardial Infarction
- Sponsor
- Oxford University Hospitals NHS Trust
- Enrollment
- 81
- Locations
- 1
- Primary Endpoint
- Thrombus Volume (mm^3)
- Status
- Completed
- Last Updated
- 7 months ago
Overview
Brief Summary
Heart attacks are caused by the sudden formation of a clot inside a diseased coronary artery which reduces blood flow beyond the blockage site. During conventional treatment of the blockage with what is known as a stent; a stainless steel tub that keeps the artery open, the clot that has formed is disrupted and is pushed further down leading to damage in smaller blood vessels supplying the heart muscle. This additional damage can lead to long-term heart muscle damage influencing recovery and wellbeing. The original concept that was tested to prevent this 'clot shower' was that of a suction device to withdraw the clot before stenting. However, this approach has not translated to patient benefit. Amongst the reasons put forward for the inefficacy of the suction device was that it does not remove the entire clot as it does not interact with it. A new device that physically interacts with the clot and traps it before pulling it out - the stent retriever - is now routinely used in stroke therapy to remove clots in the arteries supplying the brain. This device has been successfully used as a last resort to remove clots in a small number of heart attacks. The investigators hypothesize that stent retriever therapy will be more effective in clot removal than the current standard of care; suction or stenting. To study this, the investigators propose the RETRIEVE-AMI randomised controlled trial.
Investigators
Giovanni Luigi De Maria
Primary Investigator
Oxford University Hospitals NHS Trust
Eligibility Criteria
Inclusion Criteria
- •Primary PCI patient with ST elevation myocardial infarction (STEMI)
- •TIMI 0/1 flow at presentation
- •Angiographic thrombus score ≥ 4
- •Vessel diameter at site of occlusion ≥ 3.0 mm (measured by quantitative coronary angiography)
Exclusion Criteria
- •Female participant who is pregnant or lactating
- •Participant with known hypersensitivity to nickel-titanium
- •Unconscious at presentation
- •Late presenter (pain to wire time \> 12 h)
- •Class Killip III/IV and/or profound bradycardia (Heart rate \< 40 bpm)
- •Known history of kidney failure
- •Ostial occlusion
- •Highly tortuous vessel
- •Highly calcified vessel
- •Suspected (angiographically) spontaneous coronary artery dissection
Outcomes
Primary Outcomes
Thrombus Volume (mm^3)
Time Frame: During PCI prior to stent implantation (typically 30 min from start of procedure)
Assessed with Optical Coherence Tomography \[OCT\]
Device-related Target Vessel Complications
Time Frame: During PCI prior to stent implantation (typically 30 min from start of procedure)
Assessed with angiography and/or OCT
Device Deficiency
Time Frame: During PCI prior to stent implantation (typically 30 min from start of procedure)
Assessed with angiography and/or OCT
Major Adverse Cardiac and Cerebrovascular Events (MACCE)
Time Frame: Up to 30 days after PCI
MACCE
Time Frame: At 6 months after PCI
Secondary Outcomes
- Flow Volume (mm^3)(Post-stent implantation during PCI (typically 50 min after procedure start))
- Thromboatheroma Volume (mm^3)(Post-stent implantation during PCI (typically 50 min after procedure start))
- Number of Participants With Stent Underexpansion & Malapposition(Post-stent implantation during PCI (typically 50 min after procedure start))
- Thrombolysis in Myocardial Infarction (TIMI) Flow(Post-stent implantation during PCI (typically 60 min after procedure start))
- Number of Participants With Myocardial Blush Grade (MBG) < 3(Post-stent implantation during PCI (typically 60 min after procedure start))
- Angiograpicy Derived Index of Microcirculatory Resistance(Post-stent implantation during PCI (typically 60 min after procedure start))